Search

Author/Creator Moro, Pedro

2. Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study. (November 2022)

Authors:
Kracalik, Ian; Oster, Matthew E; Broder, Karen R; Cortese, Margaret M; Glover, Maleeka; Shields, Karen; Creech, C Buddy; Romanson, Brittney; Novosad, Shannon; Soslow, Jonathan; Walter, Emmanuel B; Marquez, Paige; Dendy, Jeffrey M; Woo, Jared; Valderrama, Amy L; Ramirez-Cardenas, Alejandra; Assefa...
Journal:
Lancet
Issue:
Volume 6:Number 11(2022)
Page Start:
788
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006–2015. Issue 8 (3rd August 2018)

Authors:
Miller, Elaine R.; Lewis, Paige; Shimabukuro, Tom T.; Su, John; Moro, Pedro; Woo, Emily Jane; Jankosky, Christopher; Cano, Maria
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 14:Issue 8(2018)
Page Start:
1963
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines. Issue 28 (23rd June 2021)

Authors:
Gubernot, Diane; Jazwa, Amelia; Niu, Manette; Baumblatt, Jane; Gee, Julianne; Moro, Pedro; Duffy, Jonathan; Harrington, Theresa; McNeil, Michael M.; Broder, Karen; Su, John; Kamidani, Satoshi; Olson, Christine K.; Panagiotakopoulos, Lakshmi; Shimabukuro, Tom; Forshee, Richard; Anderson, Steven; B...
Journal:
Vaccine
Issue:
Volume 39:Issue 28(2021)
Page Start:
3666
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗